Table 1 Clinical parameters of the Princess Margaret Cancer Centre cohort
From: Chromosomal instability as a prognostic marker in cervical cancer
| n = 79 | |
|---|---|
| Age (years) | |
| Median | 48 |
| Range | 26-84 |
| Tumour size | |
| ≤ 5 cm | 48 (61%) |
| > 5 cm | 31 (39%) |
| FIGO stage | |
| IA | 0 |
| IB | 24 (30%) |
| IIA | 2 (3%) |
| IIB | 35 (44%) |
| IIIA | 0 |
| IIIB | 18 (23%) |
| Pelvic or para-aortic node involvement | |
| Positive | 25 (32%) |
| Equivocal | 15 (19%) |
| Negative | 39 (49%) |
| Overall survival | |
| Deaths | 24 (31%) |
| Disease-free survival | |
| Relapses or deaths | 28 (35%) |
| Follow-up (years) | |
| Median | 6.0 |
| Range | 0.7-10.6 |
